Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety ReportsAlem Zekarias(Uppsala Monitoring Centre), Birgitta Grundmark(Uppsala Monitoring Centre)Drug SafetySeptember 25, 202010.1007/s40264-020-01000-8Cited by 40SaveCiteExport RISWatch citationsRelated PapersSupporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study|Drug Safety|2023|19